GT Medical Technologies Completes Final Close of Company’s Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
/
DateJul 15 2025
TEMPE, Ariz., July 15, 2025 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors,... Read More →